EMEA-001722-PIP01-14-M02

Key facts

Active substance
eteplirsen
Therapeutic area
Neurology
Decision number
P/0286/2019
PIP number
EMEA-001722-PIP01-14-M02
Pharmaceutical form(s)
Concentrate for solution for infusion
Condition(s) / indication(s)
Treatment of Duchenne muscular dystrophy
Route(s) of administration
Intravenous use
Contact for public enquiries
Sarepta Therapeutics Ireland Limited

E-mail: ekelly@sarepta.com
Tel. +353 868792759

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating